Robinson Bradshaw

Month: July 2009

ACLU v. Myriad Genetics: Defendants Move to Dismiss

The US Patent and Trademark Office, the University of Utah and Myriad Genetics have all filed motions seeking to dismiss the ACLU’s high-profile lawsuit attacking the patentability of genes (pdfs: USPTO Memorandum; Myriad/Utah Memorandum). In alleging that the plaintiffs lack standing to bring the lawsuit — a common procedural tactic in litigation — Myriad does not […]

The Personal Genome Project is Picking Up Steam

When the Personal Genome Project (PGP) announced earlier this summer that it was opening its doors to the next 100 participants the response was overwhelming. To date, nearly 15,000 individuals have registered with the PGP and more than 1,500 have completed the preliminary eligibility screening process. This afternoon I spoke with Jason Bobe, the PGP’s […]

MLB’s Genetic Testing Program at the Plate Again

The New York Times published a follow up piece to its story on Major League Baseball using genetic testing to confirm the reported ages of some young baseball aspirants. Last week’s GLR post examined MLB’s genetic testing program in the context of the Genetic Information Nondiscrimination Act (GINA) and has prompted further internal discussion here […]

The Genome In Silico and the Future of Whole-Genome Sequencing

In my previous post summarizing last weekend’s conference on Genetics and Ethics in the 21st Century I briefly mentioned Professor John Robertson’s discussion of the “genome in silico.” Using Illumina’s recently announced $48,000 whole-genome sequencing service as an example, Robertson wondered whether the future of whole-genome sequencing lies in converting the genome to silicon storage […]

Genomics and Personalized Medicine: Facts, Fiction, Future?

Over the weekend I took part in the 13th Conference on Genetics & Ethics in the 21st Century in Breckenridge, CO. The theme was “Genomics and Personalized Medicine, Facts, Fiction, Future?” Although the altitude (Breckenridge is at 9,600 ft) posed a problem for several participants, the conference otherwise went off without a hitch. The program […]

NHGRI Commits $9.5 Million to Spur Innovation

This week, the National Human Genome Research Institute (NHGRI) committed an additional $9.5 million to fund advancements in genome-sequencing in pursuit of its goal to “reduce the cost of sequencing a mammalian-sized genome to approximately $1,000.” Through its “Revolutionary Genome Sequencing Technologies—The $1,000 Genome” program, the NHGRI continues to drive a remarkable decline in the cost […]

Navigenics Announces Clinical Partnership with Toronto’s Medcan Clinic

Genetic testing provider Navigenics has announced a partnership with the Medcan Clinic, a preventive healthcare clinic located in Toronto, Canada. According to the press release, Medcan will use a version of the Navigenics genotyping service, in combination with family history information, to offer patients an analysis of those “genetic risks that are clinically actionable, allowing […]

MLB Meets GINA

According to an article in today’s New York Times, Major League Baseball’s department of investigations is conducting genetic testing on certain Latin American prospects in an attempt to verify their reported ages. The Times reports that MLB has confirmed that it conducts genetic testing to confirm paternity/maternity “in very rare instances and only on a […]

Genomic-Related Trademark Filings Down in 2009

Applications to register genomic-related trademarks are down by one third on an annualized basis compared to 2008. The Genomics Law Report has found that since 2004, filings of application with the US PTO to register trademarks for goods and services related to genomics grew at an irregular but generally upwards rate, with 2007 showing the […]

Pathway Genomics Launches and a Look Back at Two Years of DTC Genomics

Pathway Genomics became the latest entrant in the consumer genomics space when it publicly launched its new direct-to-consumer (DTC) genotyping service this morning. Pathway provides genotyping (or SNP testing) for a variety of genetic traits and markers including ancestral testing for $199, health and disease testing for $249 and both the health and ancestry service […]